• Home
  • Somatostatin receptor 1 ( SSTR1 ) expression as a potential predictive biomarker for response to androgen receptor signaling inhibitor (ARSI) therapy in metastatic castration-resistant prostate cancer (mCRPC).

Somatostatin receptor 1 ( SSTR1 ) expression as a potential predictive biomarker for response to androgen receptor signaling inhibitor (ARSI) therapy in metastatic castration-resistant prostate cancer (mCRPC).

Author List
Xiaolin Zhu, Daniel J Vis, Martin Sjöström, Raunak Shrestha, Jeroen Kneppers, Tessa Severson, Yanyun Zhu, Haolong Li, Tatyanah Farsh, Meng Zhang, Arian Lundberg, Thaidy Moreno Rodriguez, Adam Foye, Andre M. Bergman, Wilbert Zwart, David Alan Quigley, Rahul Raj Aggarwal, Eric J. Small, Michiel Simon Van Der Heijden, Felix Y Feng
Publication
Journal of Clinical Oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/478197476
Publication Year
2024
Publication Title
Xiaolin Zhu, Daniel J Vis, Martin Sjöström, Raunak Shrestha, Jeroen Kneppers, Tessa Severson, Yanyun Zhu, Haolong Li, Tatyanah Farsh, Meng Zhang, Arian Lundberg, Thaidy Moreno Rodriguez, Adam Foye, Andre M. Bergman, Wilbert Zwart, David Alan Quigley, Rahul Raj Aggarwal, Eric J. Small, Michiel Simon Van Der Heijden, Felix Y Feng. Somatostatin receptor 1 ( SSTR1 ) expression as a potential predictive biomarker for response to androgen receptor signaling inhibitor (ARSI) therapy in metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2024 Feb 1; 42(4_suppl):180-180.